发明名称 Oligodeoxyribonucleotides comprising O6-benzylguanine and their use
摘要 The present invention provides a single-stranded oligodeoxyribonucleotide, which (i) comprises from about 5 to 11 bases, at least one of which is a substituted or an unsubstituted O6-benzylguanine, and (ii) inactivates human AGT. The present invention also provides a single-stranded oligodeoxyribonucleotide, which can inactivate a mutant human AGT, which either is not inactivated by O6-benzylguanine or is less inactivated by O6-benzylguanine than by said single-stranded oligodeoxyribonucleotide. A phosphate of the single-stranded oligodeoxyribonucleotide can be replaced by a methylphosphonate or a phosphorothioate. The present invention also provides a composition comprising such an oligodeoxyribonucleotide. In addition, the present invention provides a method of enhancing the effect of an antineoplastic alkylating agent, which alkylates the O6 position of guanine residues in DNA, in the chemotherapeutic treatment of cancer in a mammal, which method comprises the co-administration to the mammal of a cancer-treatment effective amount of an antineoplastic alkylating agent and a chemotherapeutic treatment-enhancing amount of a present inventive oligodeoxyribonucleotide or composition thereof.
申请公布号 US6060458(A) 申请公布日期 2000.05.09
申请号 US19980023726 申请日期 1998.02.13
申请人 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES;THE PENN STATE RESEARCH FOUNDATION;ARCH DEVELOPMENT CORPORATION 发明人 MOSCHEL, ROBERT C.;PAULY, GARY T.;PEGG, ANTHONY E.;DOLAN, M. EILEEN
分类号 C07H21/04;A61K31/175;A61K31/7115;A61P35/00;A61P43/00;C07H21/00;(IPC1-7):A61K31/70;C12N5/06 主分类号 C07H21/04
代理机构 代理人
主权项
地址